Navigation Links
Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
Date:3/4/2013

NEW YORK, March 4, 2013 /PRNewswire/ -- Aquavit Pharmaceuticals Inc. has announced its newest addition to its management team, Dr. David Shafer . He has been appointed Chief Medical Technology Officer and will be leading Aquavit's R&D Medical Technology for Aquavit's product pipeline. 

Prior to joining Aquavit, Dr. Shafer launched the world's first Vectra XT 3D Imaging System, allowing patients to view a 3D simulated breast augmentation, liposuction, mommy makeover, facelift, rhinoplasty, and virtually any procedure on their own body prior to their surgery.

Dr. Shafer's passion for innovation, technology, & improving the overall patient experience, has led him to create the world's first-ever plastic surgery themed iPhone application. The App features over 1000 interactive FAQs about plastic surgery – from invasive surgeries to non-invasive procedures. Dr. Shafer has described today's plastic surgery patient as "sophisticated, inquisitive and information seeking", and created this resource with them in mind. With an eye for achieving natural looking results, Dr. Shafer has repeatedly been voted TOP DOC for Botox, Liposuction, Tummy Tuck, and Facelift among many other categories. W Magazine also picked up on the buzz, and featured Dr. Shafer as a "Beauty Talent soon to be on your speed-dial." 

"We are thrilled to have Dr. Shafer leading our medical technology pipeline development," said Sobin Chang , Aquavit's Chief Executive Officer. "Dr. Shafer will provide us with valuable input for all of our Commercial Planning and Operational needs, in addition to building KOL advocacy with Dr. Steven Fagien , our Chief Medical Officer."

Dr. Shafer is a NYC double board certified plastic surgeon, a Diplomat of the American Board of Plastic Surgery & a Member of the American Society of Plastic Surgeons. He is trained in all aspects of plastic and reconstructive surgery, but specializes in aesthetic surgery. He was trained at the world renowned Mayo Clinic, which is consistently ranked as the best in class for hospitals and surgical training. Additionally, he completed a prestigious fellowship at MEETH, making him an expert in Aesthetic Surgery.

About Aquavit

Aquavit Pharmaceuticals is a high-tech pharmaceutical company founded in New York City in 2010.  We provide comprehensive range of innovative pharmaceutical, biotech and medical device technologies, developing first of its kind, smart desktop compounding technology with AI integration and big data vertical.

Aquavit is pioneering personalized medicine using advanced technology to improve patients' health, maximize the efficiency of our medical community, and support the pharmacoeconomics of our payers.

This strategic focus is aligned with our modernized and diversified approaches. It is this combination that enables our research and development to address unmet needs.

Aquavit Pharmaceuticals aim to serve both clinicians and patients with the latest innovations in end-to-end personalized healthcare.


'/>"/>
SOURCE Aquavit Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
2. Aquavit and Green Cross Sign Strategic Collaboration MOU on IBX-001 Product Development and Commercialization in Asia
3. TauRx Pharmaceuticals Receives $10.5m Follow-On Investment from Dundee Corporation
4. Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders
5. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
6. Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
7. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
8. AVANIR Pharmaceuticals To paticipate in two conferences in March
9. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Full Year 2012 Financial Results On March 7, 2013
10. Adamis Pharmaceuticals Prevails in License Dispute Litigation
11. Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):